Anmar Razak, MD
Vascular Neurology · East Lansing, MINPI 1154545853
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $73,260 of the $85,928 with a category attached, or 85.3%. Johnson & Johnson accounts for 78.1% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2021 at $26,335 and has fallen 70.5% since, to $7,778 in 2025.
Across 208 payments — averaging $413.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$67K
- Portola Pharmaceuticals, LLC$7K
- Medtronic$6K
- Penumbra, Inc.$2K
- Stryker$1K
- Microvention, Inc.$652
- plus $2K from 23 others
Across 12 payments — averaging $1558.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$19K
What the payments were for
- Consulting fees$3000%
- Speaking & faculty fees$73,26085%
- Travel & lodging$4,7516%
- Food & beverage$7,6059%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 64 | $67,108 |
| Portola Pharmaceuticals, LLC | 9 | $6,513 |
| Medtronic(2 entities) | 33 | $6,484 |
| Penumbra, Inc. | 25 | $2,285 |
| Stryker | 22 | $1,187 |
| Microvention, Inc. | 12 | $652 |
| Imperative Care, Inc | 5 | $483 |
| Shockwave Medical, Inc | 3 | $271 |
| AstraZeneca | 2 | $121 |
| Novo Nordisk | 3 | $118 |
| Route 92 Medical, Inc. | 1 | $93 |
| Genentech USA, Inc. | 3 | $78 |
| UCB, Inc. | 3 | $60 |
| Alnylam Pharmaceuticals Inc. | 2 | $55 |
| Jazz Pharmaceuticals Inc. | 3 | $53 |
| Biogen | 2 | $44 |
| Lilly USA, LLC | 3 | $43 |
| Impulse Dynamics (USA) Inc. | 1 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Neurelis, Inc. | 2 | $28 |
| Kaneka Medical America LLC | 1 | $28 |
| Eisai Inc. | 1 | $27 |
| TG Therapeutics, Inc. | 1 | $24 |
| Abbott | 1 | $21 |
| Aucta Pharmaceuticals, Inc. | 1 | $19 |
| Argenx US, Inc. | 1 | $19 |
| Boston Scientific | 1 | $17 |
| AbbVie | 1 | $15 |
| Chiesi USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$65,861
- ANDEXXA$6,332
- Penumbra System$1,641
- ZOOM 88-T LARGE DISTAL PLATFORM$462
- STENT$318
- LINQ II$299
- TREVO$293
- WEB Aneurysm Embolization System$266
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$238
- SOLITAIRE X$215
- TARGET$164
- LVIS$164
- CEREBASE$121
- RED 72$108
- Pipeline$108
- ERIC RETRIEVAL DEVICE$108
- TUBING KIT - STROKE$108
- Benchmark$106
- EVOLVE PROLINE$104
- HYDROSOFT ADVANCED$103
How this compares
$85,928 in reported general payments places this provider in the 85th percentile of 29 vascular neurology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 17 | $156 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in East Lansing
- Mounzer Yassin KassabEast Lansing$443K
- Cara GuminikEast Lansing$2K
- Syed HussainEast Lansing$610
- Arshad MajidEast Lansing$36
- Aniel MajjhooFlint$432K
- David RosenbaumTraverse City$121K
- Surindar JollyWayne$25K
- Fazeel SiddiquiWyoming$14K
- Dawn KleindorferAnn Arbor$7K
- Daniel MillerDetroit$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.